MIRA Pharmaceuticals, Inc. (MIRA) Stock Overview
Explore MIRA Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
MIRA Pharmaceuticals, Inc. (MIRA)
Key Financials
Key Financials
Market Cap
32.2M
P/E Ratio
-0.53
EPS (TTM)
$-1.45
ROE
-1.41%
MIRA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, MIRA Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MIRA on the NASDAQ shows an RSI of 42.29, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.93 for the NASDAQ listing.
Key metrics behind MIRA Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.53 and a market capitalization of 32.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MIRA on the NASDAQ.